2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH DENA BATTLE
Patient Perspectives on Cytoreductive Nephrectomy after the CARMENA Trial

VIEW ALL ASCO GU 2019 VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH OLIVER SARTOR
Overall Survival Benefit and Racial Disparities in African American Men with Metastatic Prostate Cancer

VIEW ALL PCF VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH KARIM FIZAZI
ARAMIS - Efficacy and Safety of Darolutamide in nmCRPC

VIEW ALL ASCO GU 2019 VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH JAMES GULLEY
Immunotherapy Across Genitourinary Malignancies

VIEW ALL ASCO GU 2019 VIDEOS

Featured Videos

#AUA14 - Poster: Further characterization of the effects of prior or no prior docetaxel therapy on CRPC patients with bone metastases receiving Ra-223 in the phase 3 ALSYMPCA trial

ORLANDO, FL USA (UroToday.com) - Presented by Neal D. Shore,1 Nicholas J. Vogelzang,2 Peter Hoskin,3 Sten Nilsson,4 Robert Coleman,5 Christopher Parker,6 Mona Wahba,7 Karin Staudacher,8 and Oliver Sartor9 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua 2014 ra223 shore poster thumb

1Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA; 2Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, USA; 3Mount Vernon Hospital Cancer Centre, Northwood, UK; 4Karolinska University Hospital, Stockholm, Sweden; 5Weston Park Hospital, Sheffield, UK; 6The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK; 7Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA; 8Algeta ASA (Bayer), Oslo, Norway; 9Tulane Cancer Center, New Orleans, LA, USA

Click HERE to read an exclusive report by a UroToday medical writer

 

 

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 3 Issue 4

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe